GlassScriptPhysician profile
Joel M Yarmush
NPI 1972540656
$641.50
in general payments reported to CMS, 2019-2025
9 companies · $154 in 2025
The $154 reported for 2025 was more than what 75% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $121 · 2023: $141 · 2024: $226 · 2025: $154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $501 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $500.90 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $282.18 | 2023-2025 | Kcentra, Haegarda |
| Merck Sharp & Dohme LLC | $76.66 | 2019-2024 | Bridion |
| Medtronic, INC. | $59.37 | 2023 | |
| Mallinckrodt Enterprises LLC | $57.07 | 2019 | |
| Heron Therapeutics, INC. | $48.80 | 2024-2025 | Aponvie |
| Becton, Dickinson and Company | $34.91 | 2025 | Hemosphere |
| Covidien LP | $34.89 | 2019 | |
| Fisher & Paykel Healthcare INC | $26.90 | 2025 | Fisher & Paykel Healthcare |
| Vertex Pharmaceuticals Incorporated | $20.72 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joel Yarmush listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.